Business · Companies · 5 hrs ago
Nazca puts Spanish supplements maker Nutris up for sale
Nazca Capital is seeking a buyer for Nutris, a Spanish company that makes gummy vitamins and other supplements.
Nutris is based in Madrid and also supplies ingredients and probiotics to laboratories and supplement makers.
Nazca took a majority stake in 2021, when Nutris had sales of about €25 million; the company has since grown to more than three times that size.
Nutris expects about €80 million in revenue and €20 million in earnings in 2026.
The sale has attracted interest from international investment firms, and non-binding offers are expected by 1 December.
Nazca and Nutris’s founders intend to reinvest alongside the new owner, while the company’s estimated sale value is €250 million to €300 million.
Nazca Capital has launched a sale process for its majority stake in Spanish supplements maker Nutris, with a potential valuation of €250 million to €300 million.
The company has drawn interest from international private equity firms, and non-binding offers are expected on 1 December.
Nutris makes gummy-form supplements for other companies and distributes ingredients and probiotics to nutraceutical laboratories and supplement makers.
The company expects to close 2026 with about €80 million in revenue and around €20 million in EBITDA.
Nazca and Nutris founders Pedro de la Fuente and Inés de Santos intend to reinvest alongside the company’s next owner.
- Who
- Nazca Capital is selling its majority stake in Nutris. The founders, Pedro de la Fuente and Inés de Santos, also intend to reinvest with the new owner.
- What
- Nutris has been put up for sale, with its value estimated at €250 million to €300 million.
- When
- Non-binding offers are expected on 1 December. The sale process is in its preliminary stages.
- Where
- Nutris is a Spanish company headquartered in Madrid.
- Why
- Not stated
This story does not have two clearly opposing sides.
Nutris was founded.
Nazca Capital acquired a majority stake in Nutris, when sales were about €25 million.
Potential buyers are expected to submit non-binding offers.
Nutris expects to close the year with about €80 million in revenue and around €20 million in EBITDA.
- Estimated sale valuation
- €250 million to €300 million
- Expected revenue in 2026
- About €80 million
- Expected EBITDA in 2026
- Around €20 million
- Founded
- 2013
- Headquarters
- Madrid, Spain
- Expected offers date
- 1 December